Skip to main content
BLLN logo
BLLN
(NASDAQ)
BillionToOne, Inc.
$83.38-- (--)
Loading... - Market loading

BillionToOne (BLLN) Stock Price & Financial Analysis

BillionToOne Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$78.01 - $84.99
52-Week High$138.70
52-Week Low$61.96
Open$81.71
Volume676.34K
Average Volume (3M)613.77K
Market Cap1.83B
Shares Outstanding21.23M
P/E Ratio (TTM)165.99
Price to Sales (P/S)5.75
Price to Book (P/B)3.65
EV/EBITDA75.88
Revenue (TTM)305.11M
Net Income (TTM)10.57M
Free Cash Flow (TTM)15.67M
EPS (TTM)$0.37
Profit Margin3.46%
Operating Margin5.25%
Return on Equity (ROE)2.20%
Debt to Equity0.13
50-Day MA$79.30
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About BillionToOne

What is the current stock price for BLLN?

As of the latest trading session, BLLN stock trades at $83.38. The 52-week range is $61.96–$138.70, with a day range of $78.01–$84.99.

What is the P/E ratio for BLLN?

BillionToOne's trailing P/E ratio is 166.0, meaning investors pay $166.0 for every $1 of annual earnings. BillionToOne operates in the Healthcare sector.

Does BLLN pay dividends?

BillionToOne does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for BLLN?

Based on 3 analysts, the consensus for BLLN is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of BLLN?

BillionToOne's market capitalization is $1.77B, classifying it as a small-cap company. BillionToOne operates in the Healthcare sector within the Diagnostics & Research industry.